Direct Investments

New investment into innovative healthcare company, Medherant

Mercia Technologies announced today that it has completed a new direct investment of £650,000 into Medherant Limited, a University of Warwick spinout that has developed a transdermal drug delivery system in the form of a patch.

To read the full Stock Exchange announcement, click here.